Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial-Reference-Cited by-同舟云学术

Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial

Published:2022-03 Issue:3 Volume:34 Page:198-204
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Khaw P.,Do V.,Lim K.,Cunninghame J.,Dixon J.,Vassie J.,Bailey M.,Johnson C.,Kahl K.,Gordon C.,Cook O.,Foo K.,Fyles A.,Powell M.,Haie-Meder C.,D'Amico R.,Bessette P.,Mileshkin L.,Creutzberg C.L.,Moore A.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference21 articles.

1. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02;Peters;J Clin Oncol,2010

2. Radiotherapy quality assurance for head and neck squamous cell carcinoma;Van Gestel;Front Oncol,2020

3. Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis;Fairchild;Radiat Oncol,2014

4. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer;de Boer;Ann Oncol,2018

5. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial;de Boer;Lancet Oncol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy trial quality assurance processes: a systematic review;The Lancet Oncology;2024-03

2. Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer;Radiation Oncology;2022-11-16

3. Why quality assurance is necessary in gynecologic radiation oncology;International Journal of Gynecologic Cancer;2022-03